pneumonia
etiolog
studi
perform
rural
primarili
agrarian
provinc
thailand
nakhon
phanom
border
lao
popul
sa
kaeo
border
cambodia
popul
acut
care
hospit
sa
kaeo
begin
septemb
hospit
nakhon
phanom
begin
januari
particip
elig
patient
includ
person
admit
hospit
ari
defin
evid
activ
infect
bodi
temperatur
document
within
hour
admiss
histori
fever
chill
abnorm
white
blood
cell
count
differenti
document
respiratori
tract
ill
abnorm
breath
sound
physic
examin
presenc
tachypnea
cough
sputum
product
dyspnea
enrol
blood
urin
nasopharyng
swab
specimen
collect
studi
nurs
second
blood
specimen
collect
week
enrol
serolog
test
leftov
serum
specimen
store
thailand
nation
institut
health
thainih
futur
test
elig
limit
patient
ari
clinician
obtain
chest
radiograph
within
hour
hospit
admiss
regardless
result
begin
januari
everi
patient
hospit
ari
consid
enrol
regardless
whether
chest
radiographi
perform
studi
approv
center
diseas
control
prevent
institut
review
board
protocol
ethic
review
committe
thailand
ministri
public
health
patient
guardian
provid
inform
consent
specimen
collect
use
specimen
research
purpos
clinic
specimen
collect
part
routin
clinic
care
initi
sputum
collect
discret
physician
acidfast
bacilli
stain
begin
octob
sputum
sampl
acidfast
bacilli
stain
sought
enrol
patient
blood
cultur
perform
clinic
indic
use
bacttalert
system
blood
inocul
cultur
bottl
optim
standard
aerob
growth
suffici
volum
avail
second
bottl
enhanc
growth
mycobacteria
fastidi
pathogen
nasopharyng
blood
urin
specimen
test
respiratori
pathogen
includ
rhinoviru
coronaviru
influenza
b
respiratori
syncyti
viru
human
parainfluenzavirus
chlamydia
pneumonia
human
metapneumoviru
adenoviru
streptococcu
pneumonia
center
diseas
control
prevent
thainih
test
method
describ
elsewher
test
perform
year
pathogen
includ
test
year
howev
test
pathogen
influenza
b
respiratori
syncyti
viru
adenoviru
pneumonia
conduct
studi
year
cryptococcu
antigen
test
perform
use
premier
cryptococc
antigen
enzym
immunoassay
meridian
bioscienc
sampl
cryptococc
antigen
latex
agglutin
system
meridian
thainih
subset
store
serum
sampl
collect
patient
pneumonia
etiolog
studi
enrol
maintain
thainih
serum
specimen
hivinfect
patient
defin
patient
test
posit
hiv
studi
enrol
document
evid
hiv
infect
medic
chart
enrol
januari
decemb
includ
analysi
regardless
whether
anoth
pathogen
identifi
initi
test
cryptococcu
test
also
perform
serum
sampl
randomli
select
subset
hivuninfect
patient
enrol
studi
neg
aforement
pathogen
epidemiolog
clinic
laboratori
data
collect
patient
medic
record
hospit
surveil
offic
chest
radiograph
review
independ
panel
radiologist
bangkok
describ
elsewher
determin
whether
patient
ari
symptom
consist
cm
recent
histori
cm
identifi
factor
associ
cryptococc
antigenemia
addit
inpati
outpati
medic
record
review
conduct
antigenem
patient
subset
patient
full
medic
record
avail
patient
defin
evid
exist
cm
discharg
diagnosi
cm
given
amphotericin
b
admiss
cryptococc
antigenemia
persist
long
period
infect
document
pastyear
episod
cm
also
record
fluconazol
provid
hivinfect
patient
cryptococc
prophylaxi
thailand
fluconazol
also
use
treat
candidiasi
includ
provis
hospit
evid
exist
cm
data
analyz
use
sa
softwar
version
sa
institut
nonparametr
distribut
continu
variabl
analyz
use
wilcoxon
test
twosid
p
valu
report
analys
report
except
fisher
exact
test
provid
appropri
estim
associ
total
hivinfect
studi
patient
enrol
includ
analysi
hivuninfect
patient
enrol
pathogen
identifi
specimen
patient
randomli
select
analysi
residu
store
serum
sampl
cryptococc
antigen
test
avail
hivinfect
patient
hivuninfect
patient
patient
age
group
year
tabl
hivinfect
patient
younger
hivuninfect
patient
p
like
sa
kaeo
nakhon
phanom
p
similar
proport
patient
group
male
tabl
serum
specimen
hivuninfect
patient
neg
cryptococc
antigen
serum
sampl
hivinfect
patient
test
posit
cryptococc
antigen
crag
tabl
although
higher
proport
hivinfect
patient
sa
kaeo
patient
nakhon
phanom
crag
vs
respect
p
tabl
withinyear
differ
proport
posit
statist
signific
figur
gener
upward
trend
preval
crag
time
statist
signific
observ
provinc
figur
none
hivuninfect
patient
crag
subsequ
analys
includ
hivinfect
patient
crag
patient
sa
kaeo
nakhon
phanom
tabl
differ
note
age
sex
crag
patient
crag
preval
highest
age
group
tabl
clinic
laboratori
characterist
hivinfect
patient
hospit
summar
tabl
crag
patient
less
like
patient
present
white
blood
cell
count
vs
p
sputum
product
vs
p
like
present
dyspnea
vs
p
mean
median
white
blood
cell
count
significantli
lower
crag
patient
patient
p
crag
patient
experienc
longer
hospit
stay
vs
day
p
nine
crag
patient
patient
die
hospit
discharg
tabl
crag
patient
document
caus
death
medic
record
die
cm
eightyfour
crag
patient
patient
chest
radiographi
perform
patient
radiograph
evid
pneumonia
differ
identifi
chest
radiograph
find
crag
patient
tabl
among
hivinfect
patient
common
pathogen
detect
method
tuberculosi
rhinoviru
cryptococcu
speci
detect
crag
tabl
basi
test
nasopharyng
swab
urin
serum
sampl
frequent
detect
pathogen
among
crag
patient
rhinoviru
test
coronaviru
test
pneumonia
test
nineteen
crag
patient
coinfect
detect
specimen
tabl
blood
cultur
perform
crag
patient
pathogen
identifi
patient
frequent
identifi
pathogen
blood
cultur
cryptococcu
speci
found
patient
crag
patient
anoth
pathogen
identifi
blood
cultur
tabl
statist
signific
differ
preval
coinfect
crag
patient
hiv
infect
data
shown
inpati
andor
outpati
medic
record
avail
crag
patient
sa
kaeo
nakhon
phanom
patient
least
document
opportunist
infect
past
year
includ
pneumocysti
pneumonia
case
tuberculosi
case
candidiasi
case
cell
count
past
month
avail
crag
patient
median
cell
count
rang
twentyseven
crag
patient
evid
cm
studi
admiss
evid
cm
past
year
studi
admiss
patient
cryptococcu
speci
isol
blood
cultur
like
evid
cm
studi
admiss
vs
p
past
year
vs
p
without
cryptococcu
isol
blood
cultur
patient
cm
admiss
receiv
amphotericin
b
fluconazol
hospit
receiv
amphotericin
b
receiv
fluconazol
receiv
document
antifung
drug
eleven
patient
provid
inform
admiss
fluconazol
statu
report
alreadi
take
fluconazol
possibl
prophylaxi
past
undocu
episod
cm
thirtyseven
crag
patient
evid
cm
admiss
past
year
given
fluconazol
admiss
given
itraconazol
either
initi
prophylaxi
continu
undocu
prophylaxi
treatment
suspect
undocu
cryptococc
infect
candidiasi
patient
document
histori
candidiasi
addit
patient
without
evid
cm
admiss
year
admiss
report
alreadi
take
fluconazol
time
admiss
record
cell
count
cell
count
threshold
fluconazol
prophylaxi
recommend
thailand
thirti
patient
neither
evid
cm
admiss
past
year
altern
etiolog
infect
identifi
diagnost
test
six
howev
discharg
diagnosi
pneumocysti
jirovecii
pneumonia
typic
determin
empir
set
test
perform
pneumonia
etiolog
studi
clinic
chest
radiograph
characterist
compar
crag
patient
without
evid
cm
histori
cm
patient
dyspnea
remain
statist
significantli
differ
group
among
nonmeningit
crag
patient
compar
among
patient
p
mean
white
blood
cell
count
among
crag
cmneg
patient
median
statist
significantli
differ
patient
cryptococc
infect
long
one
signific
threat
health
surviv
person
aid
exclud
rhinoviru
pathogen
uncertain
found
cryptococc
infect
second
common
infect
among
hivinfect
patient
hospit
ari
thailand
cryptococc
antigenemia
found
hivuninfect
patient
suggest
cryptococcu
might
rare
ever
etiolog
agent
ari
immunocompet
patient
thailand
interest
cryptococc
antigenemia
frequent
among
hivinfect
patient
eastern
provinc
sa
kaeo
compar
northeastern
provinc
nakhon
phanom
reason
unknown
clinic
differ
found
antigenem
nonantigenem
hivinfect
patient
suggest
sign
symptom
alon
insuffici
criteria
determin
hospit
patient
ari
warrant
cryptococcu
test
respiratori
sign
symptom
dyspnea
sputum
product
differ
patient
versu
without
cryptococc
antigenemia
howev
characterist
subject
individu
level
unlik
use
diagnost
total
white
blood
cell
count
significantli
lower
among
antigenem
nonantigenem
patient
differ
patient
evid
cm
exclud
antigenem
group
suggest
antigenem
patient
cm
advanc
hiv
infect
antigenem
patient
without
cm
hivinfect
patient
hospit
ari
without
clinic
evid
cm
may
repres
group
crag
test
would
lead
earlier
diagnosi
cryptococc
infect
treatment
might
improv
outcom
although
antigenem
patient
histori
cm
might
explain
antigenemia
major
evid
exist
prior
cm
high
proport
crag
patient
evid
cm
detect
coinfect
suggest
cryptococcu
speci
possibl
etiolog
agent
respiratori
ill
cryptococc
antigenemia
particularli
high
titer
shown
sensit
specif
marker
futur
cm
prognost
factor
increas
risk
death
certain
popul
meya
et
al
demonstr
asymptomat
antigenem
patient
given
fluconazol
improv
surviv
asymptomat
antigenem
patient
given
fluconazol
crag
patient
without
overt
sign
symptom
cryptococc
infect
window
opportun
treatment
might
exist
administ
amphotericin
b
highdos
fluconazol
reduc
risk
develop
cm
blood
cultur
posit
cryptococcu
shown
studi
associ
crag
among
patient
clinic
suspicion
cm
alreadi
exist
less
frequent
among
patient
without
symptom
cm
data
strongli
point
role
cryptococc
antigen
test
among
hivinfect
patient
hospit
acut
respiratori
infect
thailand
highli
sensit
specif
pointofcar
test
later
flow
assay
recent
describ
lindsley
et
al
could
facilit
rapid
test
popul
high
frequenc
cryptococcosi
thailand
evid
primari
fluconazol
prophylaxi
could
reduc
cryptococc
diseas
mortal
thailand
institut
nation
guidelin
recommend
patient
cell
count
cellsml
receiv
fluconazol
prophylaxi
despit
guidelin
frequenc
cryptococc
antigenemia
studi
least
among
patient
hospit
ari
trend
upward
time
although
statist
significantli
tempor
increas
preval
antigenemia
import
monitor
although
cryptococc
antigenemia
persist
long
period
cm
develop
cryptococc
antigenemia
patient
without
histori
cm
report
take
fluconazol
concern
deserv
studi
analysi
sever
limit
first
patient
medic
record
avail
subset
patient
might
repres
overal
patient
popul
addit
followup
data
avail
inhibit
abil
monitor
develop
cm
surviv
among
crag
patient
without
evid
mening
second
studi
perform
rural
area
thailand
hivinfect
patient
thailand
live
bangkok
exposur
cryptococcu
speci
hivinfect
patient
might
differ
exposur
rural
area
result
might
generaliz
entir
popul
third
p
jirovecii
wellknown
fungal
agent
pneumonia
hivinfect
patient
southeast
asia
includ
diagnost
test
pneumonia
etiolog
studi
although
patient
medic
record
found
discharg
diagnos
p
jirovecii
pneumonia
rule
presenc
agent
patient
caus
respiratori
symptom
final
attempt
detect
cryptococcu
speci
lung
tissu
respiratori
specimen
patient
enrol
studi
thu
demonstr
conclus
caus
ari
patient
howev
antigenemia
indic
activ
infect
mani
patient
etiolog
agent
identifi
despit
test
multipl
common
pathogen
even
without
definit
evid
causal
link
ari
high
preval
cryptococc
antigenemia
hospit
hivinfect
patient
ari
thailand
support
test
popul
regardless
sign
symptom
mening
summari
cryptococc
infect
secondlead
infect
detect
hivinfect
patient
present
ari
thailand
high
proport
patient
cryptococc
infect
altern
etiolog
ari
identifi
among
hivinfect
patient
hospit
ari
thailand
cryptococc
infect
among
differenti
diagnos
even
absenc
mening
healthcar
provid
thailand
test
patient
cryptococcu
treatment
antifung
agent
point
may
provid
window
opportun
prevent
seriou
health
outcom
